Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 26:13:1107237.
doi: 10.3389/fcimb.2023.1107237. eCollection 2023.

Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy

Qing Zhao  1   2 , Ning-Ning Li  3 , You-Xin Chen  1   2 , Xin-Yu Zhao  1   2
Affiliations

Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy

Qing Zhao et al. Front Cell Infect Microbiol. .

Abstract

Background: Cytomegalovirus retinitis (CMVR) is the most common and sight-threatening opportunistic retinal infection in patients with acquired immunodeficiency syndrome (AIDS) and several controversies remain to be settled. We aimed to summarize the current evidence and clarify the clinical features and prognosis of CMVR in AIDS patients.

Methods: The databases PubMed, EMBASE, and Ovid from inception to April 2022 were searched to identify the relevant studies. R software version 3.6.3 was used to perform the statistical analyses. Results in proportion with 95% confidence interval (CI) were calculated using the Freeman-Tukey variant of arcsine square transformation.

Results: We finally included 236 studies comprising 20,214 patients. CMVR in AIDS was male-dominated (88%, 95%CI 86%-89%), with 57% (95%CI 55%-60%) aged <41 years and 44% (95%CI 41%-47%) being bilaterally involved. CMVR was preponderant in AIDS patients with the following characteristics: white and non-Hispanic, homosexual, HIV RNA load ≥ 400 copies/mL, and CD4+ T-cells <50 cells/μL. The positivity of CMV-DNA in blood, aqueous humor, and vitreous humor was 66% (95%CI 52%-79%), 87% (95%CI 76%-96%), and 95% (95%CI 85%-100%), respectively. The most common symptoms were blurred vision (55%, 95%CI 46%-65%), followed by asymptomatic, visual field defect, and floaters. CMVR was first diagnosed and regarded as the clue to AIDS diagnosis in 9% (95%CI 6%-13%) of CMVR patients. Approximately 85% (95%CI 76%-93%) of the CMVR patients have received cART. CMVR remission was observed in 72%-92% of patients depending on the specific category of anti-CMV therapy. The general incidence of CMVR-related RD in the entire course was 24% (95%CI 18%-29%), of which most patients received PPV with SO or gas tamponade and the rate of anatomic success was 89% (95%CI 85%-93%).

Conclusion: CMVR is a common opportunistic infection with diverse clinical features in AIDS patients, preponderant in those who are male, homosexual, or with CD4+ T-cells <50 cells/μL. Current therapies for CMVR and CMVR-related RD were shown to be effective. Early detection and routine ophthalmic screening should be promoted in AIDS patients.

Systematic review registration: PROSPERO, identifier CRD42022363105.

Keywords: Cytomegalovirus retinitis; acquired immunodeficiency syndrome; clinical feature; efficacy; meta-analysis; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA Flowchart of Study Selection.
Figure 2
Figure 2
Forest Plots of the Positivity of CMV-DNA and CMV culture of CMVR in AIDS Patients.
Figure 3
Figure 3
Forest Plots of the Retinal Area Involved of CMVR in AIDS Patients.
Figure 4
Figure 4
Forest Plots of the General Incidence of CMVR-related RD in AIDS Patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Almeida D. R., Chin E. K., Tarantola R. M., Tegins E. O., Lopez C. A., Boldt H. C., et al. . (2015). Long-term outcomes in patients undergoing vitrectomy for retinal detachment due to viral retinitis. Clin. Ophthalmol. 9, 1307–1314. doi: 10.2147/OPTH.S87644 - DOI - PMC - PubMed
    1. Arevalo J. F., Garcia R. A., Mendoza A. J. (2005). High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Eur. J. Ophthalmol. 15 (5), 610–618. doi: 10.1177/112067210501500512 - DOI - PubMed
    1. Centers for Disease Control and Prevention (CDC) . (2006). Twenty-five years of HIV/AIDS–united states, 1981-2006. MMWR Morb. Mortal. Wkly. Rep. 55 (21), 585–589. - PubMed
    1. Azen S. P., Scott I. U., Flynn H. W., Jr., Lai M. Y., Topping T. M., Benati L., et al. . (1998). Silicone oil in the repair of complex retinal detachments. a prospective observational multicenter study. Ophthalmology 105 (9), 1587–1597. doi: 10.1016/S0161-6420(98)99023-6 - DOI - PubMed
    1. Brar M., Kozak I., Freeman W. R., Oster S. F., Mojana F., Yuson R. M. (2010). Vitreoretinal interface abnormalities in healed cytomegalovirus retinitis. Retina 30 (8), 1262–1266. doi: 10.1097/IAE.0b013e3181cea6c1 - DOI - PubMed